These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2654314)

  • 21. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
    Harada N; Okajima K; Uchiba M
    Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
    Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
    Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
    Broudy VC; Harlan JM; Adamson JW
    J Immunol; 1987 Jun; 138(12):4298-302. PubMed ID: 3495589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pentoxifylline on developmental changes in neutrophil cell surface mobility and membrane fluidity.
    Newton JA; Ashwood ER; Yang KD; Augustine NH; Hill HR
    J Cell Physiol; 1989 Sep; 140(3):427-31. PubMed ID: 2550471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
    Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
    J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentoxifylline enhancement of defective neutrophil function and host defense in neonatal mice.
    Krause PJ; Kristie J; Wang WP; Eisenfeld L; Herson VC; Maderazo EG; Jozaki K; Kreutzer DL
    Am J Pathol; 1987 Nov; 129(2):217-22. PubMed ID: 3674202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new method of measuring red cell deformability and the effects of pentoxifylline.
    Isogai Y; Mochizuki K; Ashikaga M
    Curr Med Res Opin; 1981; 7(6):352-8. PubMed ID: 7238085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-selectin (CD62L) cross-linking signals neutrophil adhesive functions via the Mac-1 (CD11b/CD18) beta 2-integrin.
    Simon SI; Burns AR; Taylor AD; Gopalan PK; Lynam EB; Sklar LA; Smith CW
    J Immunol; 1995 Aug; 155(3):1502-14. PubMed ID: 7543524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.
    van Leenen D; van der Poll T; Levi M; ten Cate H; van Deventer SJ; Hack CE; Aarden LA; ten Cate JW
    J Immunol; 1993 Aug; 151(4):2318-25. PubMed ID: 8345209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of leukocyte adherence and transendothelial migration in cultured human liver vascular endothelial cells by prostaglandin E1.
    Lou J; Bühler L; Deng S; Mentha G; Montesano R; Grau GE; Morel P
    Hepatology; 1998 Mar; 27(3):822-8. PubMed ID: 9500713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways.
    Montecucco F; Steffens S; Burger F; Da Costa A; Bianchi G; Bertolotto M; Mach F; Dallegri F; Ottonello L
    Cell Signal; 2008 Mar; 20(3):557-68. PubMed ID: 18164590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of recombinant activated protein C and low-dose heparin on neutrophil-endothelial cell interactions in septic shock.
    Kirschenbaum LA; Lopez WC; Ohrum P; Tsen A; Khazin J; Astiz ME
    Crit Care Med; 2006 Aug; 34(8):2207-12. PubMed ID: 16775572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Modulators of leukocytic functions].
    Nguyen P; Broussas M; Hézard N; Cornillet P; Potron G
    J Mal Vasc; 1998 Apr; 23(2):119-24. PubMed ID: 9608925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pentoxifylline-induced modulation of human leukocyte function in vitro.
    Josaki K; Contrino J; Kristie J; Krause P; Kreutzer DL
    Am J Pathol; 1990 Mar; 136(3):623-30. PubMed ID: 2316627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic potential of pentoxifylline. A hemorheologically active drug.
    Schröer RH
    Angiology; 1985 Jun; 36(6):387-98. PubMed ID: 3927788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of neonatal neutrophil function by pentoxifylline.
    Krause PJ; Maderazo EG; Contrino J; Eisenfeld L; Herson VC; Greca N; Bannon P; Kreutzer DL
    Pediatr Res; 1991 Feb; 29(2):123-7. PubMed ID: 2014147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifylline.
    Ambrus JL; Ambrus CM; Gastpar H; Bannerman R; Bettigole R; Friedman S
    J Med; 1979; 10(6):445-56. PubMed ID: 299453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of prostacyclin in the protective effects of pentoxifylline and other xanthine derivatives in endotoxin action in mice.
    Schade UF
    Eicosanoids; 1989; 2(3):183-8. PubMed ID: 2517031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentoxifylline.
    Samlaska CP; Winfield EA
    J Am Acad Dermatol; 1994 Apr; 30(4):603-21. PubMed ID: 8157787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ARDS, neutrophils, and pentoxifylline.
    Mandell GL
    Am Rev Respir Dis; 1988 Nov; 138(5):1103-5. PubMed ID: 3059888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.